Reproductive safety of vaccination with Vista 5 L5 SQ near breeding time as determined by the effect on conception rates.

Reproductive safety of vaccination with Vista 5 L5 SQ near breeding time as determined by the effect on conception rates. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Reproductive safety of vaccination with Vista 5 L5 SQ near breeding time as determined by the effect on conception rates. Abstract Text:

Michael Bolton,David Brister,Bill Burdett,Harold Newcomb,Scott Nordstrom,Bill Sanders,Tom Shelton,Michael Bolton,David Brister,Bill Burdett,Harold Newcomb,Scott Nordstrom,Bill Sanders,Tom Shelton,

Replacement heifers (N=799; 10 to 13 months of age) were vaccinated with Vista 5 L5 SQ (Intervet; a reconstituted vaccine-bacterin product containing modified-live cultures of infectious bovine rhinotracheitis [IBR] virus, bovine viral diarrhea virus [BVDV; types 1 and 2], parainfluenza-3 virus, and bovine respiratory syncytial virus and inactivated cultures of Leptospira serovars canicola, grippotyphosa, hardjo, icterohaemorrhagiae, and pomona with a proprietary adjuvant) at either 40 plus/minus 5 days (control; n=399) or 3 days (test; n=400) before peak breeding day. By 40 plus/minus 5 days before peak breeding day, heifers in both groups had greater average titers to IBR, BVDV types 1 and 2, and four of the five Leptospira antigens assessed as compared with prevaccination titers on day -90 plus/minus 25 days. Conception rates were not affected by treatment. This study suggests that conception rates will not differ between heifers vaccinated with Vista 5 L5 SQ 3 days before breeding and those vaccinated approximately 40 days before breeding.

Reproductive safety of vaccination with Vista 5 L5 SQ near breeding time as determined by the effect on conception rates. Publishing Authors By Initials

M Bolton,D Brister,B Burdett,H Newcomb,S Nordstrom,B Sanders,T Shelton,M Bolton,D Brister,B Burdett,H Newcomb,S Nordstrom,B Sanders,T Shelton,

For similar therapeutics: biological therapy: immunotherapy: immunization: immunotherapy, active: vaccination research abstracts see: therapeutics: biological therapy: immunotherapy: immunization: immunotherapy, active: vaccination research

PUBMED ID PMID:

MEDLINE DATE:

Reproductive safety of vaccination with Vista 5 L5 SQ near breeding time as determined by the effect on conception rates. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Veterinary therapeutics : research in applied vete

VOLUME: 8

Page Numbers: 177-82

Journal Abbreviation: Vet. Ther.

ISSN: 1528-3593

DAY: 3

MONTH: 12

YEAR: 2007

Reproductive safety of vaccination with Vista 5 L5 SQ near breeding time as determined by the effect on conception rates. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100936368

Reproductive safety of vaccination with Vista 5 L5 SQ near breeding time as determined by the effect on conception rates. Keywords Mesh Terms:

KEYWORDS: Vaccination

MESH TERMS: veterinary

Chemical & Substance for Abstract: Reproductive safety of vaccination with Vista 5 L5 SQ near breeding time as determined by the effect on conception rates. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Reproductive safety of vaccination with Vista 5 L5 SQ near breeding time as determined by the effect on conception rates.

AFFILIATION: Intervet, Inc., Millsboro, DE 19966, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Vet Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Reproductive safety of vaccination with Vista 5 L5 SQ near breeding time as determined by the effect on conception rates Related Publications

• Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
• Augmentation strategies to increase antidepressant efficacy.
• Bacteriorhodopsin optoelectronic synapses.
• Chronic sigmoid volvulus.
• Cognitive costs of exposure to racial prejudice.
• Cyproheptadine for pediatric intrathecal baclofen withdrawal: a case report.
• Eat smart and move more to combat arthritis.
• External auditory canal cholesteatoma: clinical and imaging spectrum.
• Factors affecting viability of fresh and frozen-thawed sheep demi-embryos.
• From dog to man: the broad spectrum of inflammatory myopathies.
• Imaging findings of cochlear nerve deficiency.
• In praise of real nurses.
• Inter-parental conflict and children's academic attainment: a longitudinal analysis.
• Non-pathogenic protein aggregates in skeletal muscle in MLF1 transgenic mice.
• Pharmacokinetic Interaction between Fosamprenavir-Ritonavir and Rifabutin in Healthy Subjects.
• Pityriasis rosea; report of three cases within one household.
• Primary jugular foramen meningioma: imaging appearance and differentiating features.
• Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
• Reproductive response to suckling manipulation in Spanish goats.
• Reproductive safety of vaccination with Vista 5 L5 SQ near breeding time as determined by the effect on conception rates.
• Spiritual well-being, anxiety, and depression in antepartal women on bedrest.
• Sudden gains in cognitive therapy of depression and depression relapse/recurrence.
• THE UNDERSTANDING ASSISTANT.
• Ten myths and one truth about generalised HIV epidemics.
• The epidemiology of fractures in England.
• The molecular neurobiology of depression.
• Use of treatment algorithms for depression.
• Using mental health consultation to decrease disruptive behaviors in preschoolers: adapting an empirically-supported intervention.
• What's new in muscle and peripheral nerve diseases?
• [Use of silicone for relining and duplicating dentures]